Sigma Healthcare's EBIT per Share for the
six
months ended in Dec. 2025 was A$0.05.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.06.
During the past 3 years, the average EBIT per Share Growth Rate was 6.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -4.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sigma Healthcare's EBIT per Share or its related term are showing as below:
ASX:SIG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -52.8 Med: 6.2 Max: 89.2
Current: 6.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sigma Healthcare was 89.20% per year. The lowest was -52.80% per year. And the median was 6.20% per year.
ASX:SIG's 3-Year EBIT Growth Rate is ranked better than 56.6% of 106
companies
in the Medical Distribution industry
Industry Median: 4.1
vs ASX:SIG: 6.20
Sigma Healthcare (ASX:SIG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sigma Healthcare EBIT per Share Related Terms
Sigma Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Sigma Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sigma Healthcare (ASX:SIG) has a EBIT per Share of A$0.06 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sigma Healthcare and its competitors. According to the industry distribution chart, Sigma Healthcare ranks #46 out of 106 companies in the Medical Distribution industry, placing it in the top 43.4%.
Is Sigma Healthcare's EBIT per Share too high?
Sigma Healthcare's current EBIT per Share is A$0.06. Based on the distribution chart, Sigma Healthcare ranks #46 out of 106 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's EBIT per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #46 out of 106 companies for EBIT per Share. This puts Sigma Healthcare in the upper half of its industry. The industry median EBIT per Share is 4.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.10, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sigma Healthcare and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current EBIT per Share is A$0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.79 — trading 654.1% above its estimated fair value. The current EBIT per Share is A$0.06. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current EBIT per Share is A$0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of A$2.79 is trading 654.1% above its estimated GF Value™ of A$0.37.
GuruFocus considers Sigma Healthcare to be Significantly Overvalued.
Key valuation signals for ASX:SIG:
EBIT per Share: A$0.06
GF Value™: A$0.37 vs. price of A$2.79 (654.1% above fair value)
No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score
Get the complete analysis for ASX:SIG
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SIG has been successfully added to your 
